The influence of ROS1 fusion partners and resistance mechanisms in ROS1-TKI-treated non-small cell lung cancer patients. [PDF]
Zwierenga F +8 more
europepmc +1 more source
Versatile molecular tools enabling customizable DNA methylation editing in Arabidopsis. [PDF]
He L +7 more
europepmc +1 more source
Safety, pharmacokinetic, pharmacodynamic, and efficacy properties of orally administered APG-2449 in patients with advanced <i>ALK</i> <sup><i>+</i></sup> and <i>ROS1</i> <sup><i>+</i></sup> non-small-cell lung cancer: a multicentre, open-label, single-arm phase 1 trial. [PDF]
Ma Y +25 more
europepmc +1 more source
A remarkable year for NSCLC: Seven new FDA approvals in 2025 across molecular targets. [PDF]
Tomić K, Vranić S.
europepmc +1 more source
Case Report: Clinical metastasis characteristics of lung adenosquamous carcinoma with <i>ROS1</i> rearrangement. [PDF]
Chen X +6 more
europepmc +1 more source
Molecular and immune biomarker testing in squamous-cell lung cancer: Effect of current and future therapies and technologies [PDF]
Bradley, Jeffrey D, et al,
core +1 more source
ROS1 Expression Correlates With Inguinal Lymph Node Affection in Vulvar Cancer Patients: A Retrospective Study. [PDF]
Nigdelis MP +10 more
europepmc +1 more source
An updated review on systemic therapy for brain metastases in non-small cell lung cancer. [PDF]
Louis S +4 more
europepmc +1 more source

